BiochemistryACS Applied Materials & InterfacesPeer-reviewed
Dual-targeting strategy to repurpose Cetuximab with HFn nanoconjugates for immunotherapy of triple-negative breast cancer
Linda Barbieri, Lucia Salvioni, Andrea Banfi…·Davide Prosperi
This paper develops a dual-targeting nanoconjugate using Cetuximab and H-ferritin to enhance immunotherapy for TNBC by improving ADCC and tumor targeting.
6 citations